Innovation Pharmaceuticals Inc (IPIX)

[noretreat]

I'm pretty sure that at 28 days the efficacy of the lowest dose arm was equal to the highest dose and that the moderate dose was directionally lower. At earlier points the results flipped around a little. All 3 were directionally (not significant at n=50) lower than daptomycin. Closer analysis of this suggests that at higher n size there is a better than 50/50 chance of equivalence with daptomycin.

It might be handy to keep this sheet at your fingertips:

http://files.shareholder.com/downloads/ABEA-4ITCYZ/1997024712x0x611205/FEA66C67-D02F-4FF2-B230-AA711F46ED7F/PMX-30063_Antibiotic_Fact_Sheet_Nov_2012_.pdf